<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Genomics</journal-id><journal-id journal-id-type="publisher-id">CG</journal-id><journal-title>Current Genomics</journal-title><issn pub-type="ppub">1389-2029</issn><issn pub-type="epub">1875-5488</issn><publisher><publisher-name>Bentham Science Publishers Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19412415</article-id><article-id pub-id-type="pmc">2647154</article-id><article-id pub-id-type="publisher-id">CG-8-423</article-id><article-id pub-id-type="doi">10.2174/138920207783591726</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Role of Insulin and Growth Hormone/Insulin-Like Growth Factor-I Signaling in Lifespan Extension: Rodent Longevity Models for Studying Aging and Calorie Restriction</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chiba</surname><given-names>T</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Yamaza</surname><given-names>H</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shimokawa</surname><given-names>I</given-names></name></contrib></contrib-group><aff id="aff">Department of Investigative Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan</aff><author-notes><corresp id="cor1"><label>*</label>Address correspondence to this author at the Department of Investigative Pathology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan; Tel: (81)-95-819-7050; Fax: (81)-95-819-7052; E-mail: <email xlink:href="takuya@nagasaki-u.ac.jp">takuya@nagasaki-u.ac.jp</email></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2007</year></pub-date><volume>8</volume><issue>7</issue><fpage>423</fpage><lpage>428</lpage><history><date date-type="received"><day>1</day><month>10</month><year>2007</year></date><date date-type="rev-recd"><day>15</day><month>10</month><year>2007</year></date><date date-type="accepted"><day>18</day><month>10</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9;2007 Bentham Science Publishers Ltd.</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/2.5/">http://creativecommons.org/licenses/by/2.5/</uri>), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>Insulin/insulin-like growth factor-I (IGF-I) pathways are recognized as critical signaling pathways involved in the control of lifespans in lower organisms to mammals. Caloric restriction (CR) reduces plasma concentration of insulin, growth hormone (GH), and IGF-I. CR retards various age-dependent disorders such as nuerodegenerative diseases and extends lifespan in laboratory rodents. These beneficial effects of CR are partly mimicked in spontaneous or genetically engineered rodent models of reduced insulin and GH/IGF-I axis. Most of these long-living rodents show increased insulin sensitivity; however, recent study has revealed that some other rodents show normal or reduced insulin sensitivity. Thus, increased insulin sensitivity might be not prerequisite for lifespan extension in insulin/GH/IGF-I altered longevity rodent models. These results highlighted that, for lifespan extension, the intracellular signaling molecules of insulin/GH/IGF-I pathways might be more important than actual peripheral or systemic insulin action.</p></abstract><kwd-group><title>Key Words</title><kwd>Insulin</kwd><kwd>GH</kwd><kwd>IGF-I</kwd><kwd>calorie restriction.</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Compared to animals allowed to access food freely, moderate restriction of food intake, but not malnutrition, reduces morbidity and mortality in laboratory animals [<xref ref-type="bibr" rid="R1">1</xref>]. This effect, often noted as the anti-aging effects of caloric restriction (CR), has been recognized as a result from the restriction of calorie intake, but not from the restriction of a specific food component and not from a reduction of the toxic contaminants in food [<xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R3">3</xref>]. From an evolutionary viewpoint, the effect of CR appears to be explained by organisms having evolved adaptation mechanisms in their neuroendocrine systems to maximize survival during periods of food shortage [<xref ref-type="bibr" rid="R4">4</xref>]. Thus, it is believed that CR can, at least in part, regulate the aging processes through its effects on endocrine and/or neural regulatory systems [<xref ref-type="bibr" rid="R2">2</xref>]. The underlying molecular mechanism of regulation of the neuroendocrine system by CR remains to be fully elucidated; however, insulin, the GH/IGF-I axis, and leptin have been proposed as potential molecular mediators of the adaptive response to CR [<xref ref-type="bibr" rid="R5">5</xref>-<xref ref-type="bibr" rid="R8">8</xref>]. </p><p>In many rodents, spontaneously or targeted gene modifications of insulin and the GH/IGF-I axis results in lifespan extension (see review [<xref ref-type="bibr" rid="R9">9</xref>-<xref ref-type="bibr" rid="R12">12</xref>]). Thus CR and these rodent insulin/GH/IGF-I models share, at least in part, a molecular mechanism of longevity. However, CR has been shown to also extend lifespan in GH-deficient long-lived Ames dwarf mice [<xref ref-type="bibr" rid="R13">13</xref>]. Furthermore, we found that CR significantly extended the lifespan of pituitary specific GH-antisense transgenic (TG) rats, which have reduced plasma levels of insulin and IGF-I [<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref>]. These findings suggest that there might be different pathways in lifespan extension by GH/IGF-I suppression and CR; although it is possible that they share some of the same regulatory molecules in the insulin/GH/IGF-I pathway.</p><p>In lower organisms, long-lived mutants in <italic>C. elegans</italic> have provided a body of evidence about molecular mechanisms underlying longevity [<xref ref-type="bibr" rid="R16">16</xref>]. The <italic>C. elegans</italic> neurosecretory signaling system regulates whether animals enter the reproductive life cycle or have an arrest in development at the long-lived dauer diapause stage. The <italic>daf-2</italic> gene encodes an insulin/IGF-I like receptor, a critical gene in the genetic pathway that mediates this endocrine signaling in <italic>C. elegans</italic> [<xref ref-type="bibr" rid="R17">17</xref>]. The <italic>age-1</italic> gene [<xref ref-type="bibr" rid="R18">18</xref>] acts in the same signaling pathway as <italic>daf-2</italic>, and is closely related to a family of mammalian phosphatidylinositol 3-kinase (PI3K) p110 catalytic subunits under the insulin/IGF-I signaling pathway [<xref ref-type="bibr" rid="R19">19</xref>]. It has been also reported that mutations in the <italic>Drosophila</italic> equivalents of <italic>daf-2</italic> (<italic>InR</italic>), and <italic>chico</italic>, a fruit fly insulin receptor substrate (IRS), indicate that these genes have roles in body and organ size determination as well as in lifespan [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref>]. Reduction of function in <italic>InR</italic> mutants and the null mutation of <italic>chico</italic> increased the mean lifespan in female flies. These findings suggest that insulin/IGF-I signaling is a highly conserved longevity signal from lower to higher organisms.</p><p>In this brief review, we first discuss longevity rodent models that have modified insulin/GH/IGF-I pathways. These include spontaneous dwarf mutations and genetically altered rodents with increased lifespan. Later, we speculate the involvement of WD-repeat protein 6 (WDR6) as a candidate for the regulator of insulin/IGF-I signaling, which controls metabolism and longevity in the brain [<xref ref-type="bibr" rid="R22">22</xref>].</p><sec><title>Insulin and GH/IGF-I Axis in Rodent Longevity Models</title><p>Table <bold><xref ref-type="table" rid="T1">1</xref></bold> shows rodent longevity models with modified insulin/GH/IGF-I signals. In mammals, the production of IGF-I is stimulated by pituitary GH. <italic>Prop-1</italic> (Ames mice) and <italic>pit-1</italic> (Snell mice) mutant dwarf mice live longer than controls, with defects of transcription factors controlling differentiation of the anterior pituitary during fetal development [<xref ref-type="bibr" rid="R23">23</xref>]. These mice are also prolactin (PRL) and thyroid-stimulating hormone (TSH) deficient. However, it is thought that inhibition of the GH/IGF-I axis is the primary effector on lifespan extension of these mice because GH overexpression mice show resemble an accelerated aging phenotype, with a shorter lifespan and earlier loss of fertility [<xref ref-type="bibr" rid="R24">24</xref>]. Both Ames and Snell mice show increased insulin sensitivity [<xref ref-type="bibr" rid="R25">25</xref>,<xref ref-type="bibr" rid="R26">26</xref>]. </p><p>Another pituitary mutation that causes dwarfism was found in <italic>lit/lit</italic> mice. The responsive gene in these mice is the GH-releasing hormone receptor (<italic>Ghrhr</italic>) [<xref ref-type="bibr" rid="R27">27</xref>]. <italic>Ghrhr<sup>lit/lit</sup></italic> mice have low levels of GH, IGF-I with prolonged lifespan [<xref ref-type="bibr" rid="R28">28</xref>]. Data from the <italic>Ghrhr<sup>lit/lit</sup></italic> mice also suggest that changes in the GH/IGF-I axis could be sufficient to extend lifespan of dwarf mice, because these mice have normal PRL, TSH and thyroid hormone levels. <italic>Ghrhr<sup>lit/lit</sup></italic> mice appear to have normal insulin responses compared to wild type mice [<xref ref-type="bibr" rid="R29">29</xref>]. However, double mutant mice of <italic>Ghrhr </italic>and PRL-receptor showed decreased insulin sensitivity in old age because of increased adiposity [<xref ref-type="bibr" rid="R29">29</xref>]. This contrasts with the results of the GH- and PRL-deficient Ames and Snell mice described above. </p><p>Pituitary specific GH-antisense TG rats show increase lifespan with lower serum insulin, IGF-I compared to Wistar rats, which have same genetic background [<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref>]. These rats have increased insulin action to reduce blood glucose; however, insulin-independent glucose-lowering effects have also been suggested [<xref ref-type="bibr" rid="R30">30</xref>,<xref ref-type="bibr" rid="R31">31</xref>]. These rats show a moderate reduction of the GH/IGF-I axis compared to Ames or Snell dwarf mice whose GH/IGF-I axis is almost completely suppressed. Similar to these dwarf mice, CR upon GH-antisense TG rats have an extended lifespan with further reduction of insulin/IGF-I levels [<xref ref-type="bibr" rid="R14">14</xref>]. </p><p>The murine equivalents to human Laron syndrome are GH receptor/binding protein homozygous knockout mice (<italic>GHR/BP<sup>-/-</sup></italic>) [<xref ref-type="bibr" rid="R32">32</xref>]. The human and murine <italic>GHR/BP</italic> gene encodes for two proteins; GH receptor and GH receptor binding protein, a truncated form of a receptor. GHR/BP KO mice have a longer lifespan compared to control wild type mice [<xref ref-type="bibr" rid="R33">33</xref>]. These mice have a markedly reduced plasma concentration of IGF-I, and a dwarf phenotype with increased insulin sensitivity [<xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R34">34</xref>]. GHR/BP deficiency impairs the beneficial effects of CR on lifespan extension and increases insulin sensitivity [<xref ref-type="bibr" rid="R35">35</xref>]. As well, CR increases insulin sensitivity in control mice, but does not further increase insulin sensitivity in GHR/BP<sup>-/-</sup> mice [<xref ref-type="bibr" rid="R35">35</xref>].</p><p>In the knockout mice heterozygous for the IGF-I receptor (<italic>Igf1r<sup><bold>+/-</bold></sup></italic>), significant lifespan extension was observed in female mice, whereas homozygous knockout mice died at birth, probably as a result of respiratory failure [<xref ref-type="bibr" rid="R36">36</xref>]. The body size of these mice is almost normal and they have no detectable alterations in reproductive development and function. Male <italic>Igf1r<sup><bold>+/-</bold></sup></italic> mice show reduced insulin sensitivity, whereas females showed increased insulin sensitivity [<xref ref-type="bibr" rid="R36">36</xref>]. Mouse embryonic fibroblasts (MEFs) from <italic>Igf1r<sup><bold>+/-</bold></sup></italic> mice show reduced IGF-I receptor (IGF-IR) signaling in response to IGF-I addition compared to MEFs from wild type mice [<xref ref-type="bibr" rid="R36">36</xref>]. Namely, tyrosine phosphorylation levels of IGF-IR, IRS-1, and p66<sup>shc</sup> proteins are decreased in MEFs from <italic>Igf1r<sup><bold>+/-</bold></sup></italic> mice. Moreover, it has been documented that brain specific heterozygous IGF-IR knockout mice have an increased lifespan and a significant decrease in mortality rate [<xref ref-type="bibr" rid="R37">37</xref>]. This is interesting because importance of brain insulin/IGF-I signaling is also suggested in <italic>C. elegans</italic> and <italic>Drosophila</italic> [<xref ref-type="bibr" rid="R37">37</xref>].</p><p>Fat specific insulin receptor knock out mice (FIRKO mice) show increased lifespan without reduction of the plasma IGF-I levels [<xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R39">39</xref>]. These mice show reduced body fat content, body mass index, and resistant to age-related and hyperphagia-induced insulin resistance. In adipose tissue, insulin-stimulated glucose uptake was reduced in FIRKO mice, indicating that insulin signaling is markedly decreased in the adipose tissue of these mice. However, whole body insulin sensitivity is increased in FIRKO mice probably as a result of the increased plasma adiponectin levels, especially in aged mice [<xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R39">39</xref>]. Recent study has revealed that FIRKO mice maintain high mitochondrial capacity and metabolic rates in adipose tissue [<xref ref-type="bibr" rid="R40">40</xref>]. These increased mitochondrial functions may be important for the lifespan extension seen in the FIRKO mouse.</p><p>Proto-oncogene Shc, an adaptor protein of receptor tyrosine kinase, is phosphorylated by the activation of growth factor receptors such as IGF-IR and insulin receptor (IR); a knock out mouse strain of the p66 isoform of Shc, p66<sup>shc</sup> showed a prolonged lifespan and increased oxidative stress resistance [<xref ref-type="bibr" rid="R41">41</xref>]. The mammalian <italic>Shc</italic> locus encodes three protein isoforms; p46<sup>shc</sup>, p54<sup>shc</sup>, and p66<sup>shc</sup> [<xref ref-type="bibr" rid="R42">42</xref>]. MEFs from p66<sup>shc</sup> knock out mice show more resistance to hydrogen peroxide treatment or UV radiation compared to MEFs from wild type mice [<xref ref-type="bibr" rid="R41">41</xref>]. This effect partly is mediated the induction of FoxO3a, a mammalian homologue of the <italic>C. elegans </italic>forkhead transcription factor <italic>daf-16</italic> [<xref ref-type="bibr" rid="R43">43</xref>]. This is interesting because <italic>daf-16</italic> is essential for lifespan extension in the <italic>daf-2</italic> mutant [<xref ref-type="bibr" rid="R44">44</xref>]. No information is yet available about the insulin sensitivity of p66<sup>shc-/-</sup> mice.</p><p>IRS-1 knock out (<italic>Irs1<sup>-/-</sup></italic>) female mice show increased lifespan despite moderate insulin resistance [<xref ref-type="bibr" rid="R45">45</xref>]. Same as <italic>Igf1r<sup><bold>+/-</bold></sup></italic> mice, <italic>Irs1<sup>-/-</sup></italic>mice lifespan extension is predominantly seen in females. The body weight of these mice is lower than that of wild type; however, serum IGF-I levels are not different. These mice show reduced adiposity similar to CR and FIRKO mice; however, <italic>Irs1<sup>-/-</sup></italic>  mice show moderate insulin resistance. Thus, the improvement in insulin sensitivity associated with reduced fat mass is not a prerequisite for the lifespan extension of <italic>Irs<sup>-/-</sup></italic> mice [<xref ref-type="bibr" rid="R45">45</xref>]. Tyrosine phosphorylation of IRS-1 enhances insulin sensitivity, whereas serine phosphorylation of IRS-1 by S6 kinase induces insulin resistance [<xref ref-type="bibr" rid="R46">46</xref>]. Therefore, IRS-1 has both negative and positive effects on insulin/IGF-I signaling. Lack of IRS-1 might cause predominately favorable intracellular signaling situations for cell survival causing lifespan extension through the activation of the FoxO1 protein, a forkhead transcription factor important for oxidative stress response.</p><p>IRS-2 heterozygous knock out mice, specifically in brain (<italic>bIrs2<sup><bold>+/-</bold></sup></italic>), showed increased lifespan [<xref ref-type="bibr" rid="R47">47</xref>]. Interestingly, while systemic heterozygous IRS-2 deficiency improved insulin sensitivity, brain-specific IRS-2 knock out led to insulin resistance. Although the mechanism responsible for this discrepancy is unknown, these results also support that insulin sensitivity by itself is not a prerequisite for lifespan extension in insulin/GH/IGF-I signal modified longevity rodents. Similar to IRS-1, tyrosine phosphorylation of IRS-2 by IR or IGF-IR is the first event in the activation of the intracellular insulin/IGF-I signal transduction pathway. IRS-1 and IRS-2 are the major IRS leading to glucose homeostasis, and have distinct and overlapping roles in diverse organs [<xref ref-type="bibr" rid="R48">48</xref>]. Lifespan extension in <italic>bIrs2<sup><bold>+/-</bold></sup></italic> mice might be related to the FoxO1 protein levels maintained in the brain that lead to the expression of antioxidant protein SOD2 [<xref ref-type="bibr" rid="R47">47</xref>]. These results of lifespan extension of <italic>bIrs2<sup><bold>+/-</bold></sup></italic> as well as <italic>Irs1<sup>-/- </sup></italic>mice might suggest that the mutation of particular molecules of intracellular insulin/IGF-I signaling is sufficient to induce longevity. Therefore, a reduced GH/IGF-I axis in dwarf animals and long-lived insulin/GH/IGF-I receptor modified mice might eventually change the activation of these intracellular substrate molecules including p66<sup>shc</sup> and their downstream targets for lifespan extension. Hence, reduced body size and increased insulin sensitivity might not be important and so could be separated from factors responsible for lifespan extension in such animals.</p><p>In summary, the above mentioned models suggest that decreased body weight and increased insulin sensitivity might be not prerequisites for lifespan extension in insulin/GH/IGF-I modified longevity rodents. Although there a significant effect on body weight and insulin sensitivity were seen depending on the particular factors in the breeding environments used in the study, such as diet composition, the results presented highlight that the importance of the intracellular signaling molecules of the insulin/GH/IGF-I signal rather than the upstream hormonal signals. Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) shows the sites of mutations in rodent longevity models. Pituitary GH and insulin/GH/IGF-I receptor mutations might cause favorable situations for intracellular signaling molecules, such as reduction of function IRS-1, -2 and p66<sup>shc</sup>, because knock out of these intracellular molecules extends lifespan. Recently, we isolated WDR6, a novel candidate for the intracellular insulin/IGF-I signaling molecule. Next we discuss the potential involvement of WDR6 in lifespan regulation. </p></sec><sec><title>WDR6 as a New Candidate for an Insulin/GH/IGF-I Signaling Molecule Related to Lifespan Regulation</title><p>We recently isolated and identified WDR6 as a novel molecule involved in hypothalamic insulin/IGF-I signaling with interacting IRS-4 by cDNA subrtaction method [<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R49"> 49</xref>]. IRS-1 and IRS-2 are ubiquitously expressed, while IRS-3 and IRS-4 are tissue specific, detected in significant amounts in fat and brain tissue, respectively [<xref ref-type="bibr" rid="R50">50</xref>]. IRS-4 is expressed abundantly in the arcuate nucleus, an important hypothalamic nucleus for regulation of energy and metabolism [<xref ref-type="bibr" rid="R51">51</xref>]. We found that the expression of WDR6 was decreased <italic>in vivo</italic> upon CR as well as with suppression of the GH/IGF-I axis; both treatments cause reductions of plasma insulin/IGF-I concentrations. Our <italic>in vitro</italic> study indicated that the addition of insulin or IGF-I caused increased gene expression of WDR6 in GT1-7 cells, a mouse hypothalamus derived cell line [<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R52">52</xref>]. These results suggested the presence of a feedback loop for insulin/IGF-I-mediated expression of WDR6.</p><p>WD repeats are conserved domains of approximately 40 to 60 amino acids that contain a tryptophan-aspartic acid (WD) dipeptide at their C-terminus, and have a conserved core sequence [<xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R54">54</xref>]. WDR6 was first cloned by Li <italic>et al</italic>, [<xref ref-type="bibr" rid="R55">55</xref>]. They showed that human WDR6 has 11 WD-repeat domains and shows relatively ubiquitous expression. However, we isolated the WDR6 gene in brain as a hypothalamus enriched gene [<xref ref-type="bibr" rid="R22">22</xref>] by using a cDNA subtraction method [<xref ref-type="bibr" rid="R49">49</xref>,<xref ref-type="bibr" rid="R56">56</xref>,<xref ref-type="bibr" rid="R57">57</xref>]. This expression pattern of WDR6 is consistent with another report that used a DNA microarray analysis [<xref ref-type="bibr" rid="R58">58</xref>]. WD repeat domains are involved in mediating protein-protein interactions [<xref ref-type="bibr" rid="R59">59</xref>,<xref ref-type="bibr" rid="R60">60</xref>], and WD repeat-containing proteins have a central role in many signal transduction cascades by coordinating the interaction of key signaling molecules. </p><p>We found that IRS-4 interacts with WDR6 <italic>in vivo</italic>. Our results suggested that WDR6 might regulate phosphorylation levels of the interacting protein, IRS-4 [<xref ref-type="bibr" rid="R22">22</xref>]. Interestingly, it was suggested that WDR6 and IRS-4 might also be involved in fibroblast growth factor (FGF) signaling [<xref ref-type="bibr" rid="R61">61</xref>]. Stimulation with FGF2 induced a 3-fold increase in tyrosine phosphorylated proteins, as assessed by mass spectrometry [<xref ref-type="bibr" rid="R61">61</xref>]. It has been suggested that FGF2 has an inhibitory effect on food intake and locomotor activity in rats [<xref ref-type="bibr" rid="R62">62</xref>]. Taken together, these results suggest that WDR6 may be involved in feeding and physical activities through its interaction in the brain with IRS-4.</p><p>Mice lacking IRS-4 show mild defects in growth, reproduction and glucose homeostasis [<xref ref-type="bibr" rid="R63">63</xref>]. These mice show slightly impaired responses on the oral glucose tolerance test. The insulin tolerance testing also showed these mice slightly less responsive to insulin compared to wild type; however, the effect was statistically insignificant. It was suggested that loss-of-function of IRS-4 in the brain might cause these phenotypes, because IRS-4 is predominantly expressed in the brain [<xref ref-type="bibr" rid="R63">63</xref>]. These phenotypes are somewhat similar to long-lived <italic>Irs1<sup>-/-</sup></italic> and <italic>bIrs2<sup><bold>+/-</bold></sup></italic> mice. Study is needed to find out whether WDR6 also interacts with IRS-1 and IRS-2. </p><p>It has recently been shown that WDR6 interacts with LKB1, a tumor suppressor gene encoding a serine/threonine kinase that phosphorylates AMP-activated protein kinase (AMPK), and regulates p27<sup>Kip1</sup> induction [<xref ref-type="bibr" rid="R64">64</xref>]. AMPK is a critical component in a protein kinase cascade that have a crucial role in the regulation of energy balance, particularly in the brain [<xref ref-type="bibr" rid="R65">65</xref>,<xref ref-type="bibr" rid="R66">66</xref>]. LKB1 gene expression is enriched in the hypothalamus, similar to the WDR6 gene in the brain [<xref ref-type="bibr" rid="R58">58</xref>]. The LKB1-AMPK-p27 pathway is also involved in the autophagic response, a bulk misfolded protein degradative system [<xref ref-type="bibr" rid="R67">67</xref>]. In <italic>C. elegans</italic>, autophagy genes are essential for dauer development and for lifespan extension in the <italic>daf-2</italic> mutant [<xref ref-type="bibr" rid="R68">68</xref>]. Moreover, autophagy mediates lifespan extension of <italic>C. elegans</italic> upon CR [<xref ref-type="bibr" rid="R69">69</xref>]. Autophagy is also reported to be important in lifespan extension in <italic>Drosophila</italic> [<xref ref-type="bibr" rid="R70">70</xref>]. In mammals, the induction of autophagy is a protective response against neurodegenerative diseases [<xref ref-type="bibr" rid="R71">71</xref>,<xref ref-type="bibr" rid="R72">72</xref>]. Moreover, CR prevents the age-dependent decline of autophagic proteolysis in liver cells [<xref ref-type="bibr" rid="R73">73</xref>]. Thus, it is interesting to speculate that WDR6 also regulates autophagy responses by modulating the LKB1-AMPK pathway in the brain. Further studies using genetically modified mice such as conditional knock out varieties, should help gain an understanding of the precise mechanism of WDR6 involvement in AMPK signaling as well as in insulin/IGF-I signaling in longevity.</p><p>In conclusion, increased insulin sensitivity might not be a prerequisite for lifespan extension in insulin/GH/IGF-I modified rodent longevity models. Although it is possible that different tissues show different insulin sensitivity in these longevity models, there could be more important intracellular signaling molecules in insulin/GH/IGF-I signaling, such as IRS-1, -2, and p66<sup>shc</sup>, and possibly WDR6, for lifespan extension. These molecules could be points of intervention for therapies with potential to delay the pathogenesis of age-related diseases and even the aging process. Further study is needed to reveal the importance, if any, of these molecules through identification of target transcription factors critical for lifespan extension.</p></sec></sec></body><back><ack><title>ACKNOWLEDGEMENT</title><p>This work was supported in part by The Japan Health Foundation.</p></ack><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Weindruch</surname><given-names>R.</given-names></name><name><surname>Wolford</surname><given-names>R.L</given-names></name></person-group><source>The retardation of aging and disease by dietary restriction</source><year>1988</year><publisher-loc>Springfield</publisher-loc><publisher-name>Charles C Thomas Publisher</publisher-name><fpage>436</fpage></citation></ref><ref id="R2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Masoro</surname><given-names>E.J</given-names></name></person-group><article-title>Food restriction in rodents an evaluation of its role in the study of aging</article-title><source>J. Gerontol</source><year>1988</year><volume>43</volume><fpage>B59</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">3283209</pub-id></citation></ref><ref id="R3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Masoro</surname><given-names>E.J</given-names></name></person-group><article-title>Caloric restriction and aging: an update</article-title><source>Exp. Gerontol</source><year>2000</year><volume>35</volume><fpage>299</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">10832051</pub-id></citation></ref><ref id="R4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holliday</surname><given-names>R</given-names></name></person-group><article-title>Food reproduction and longevity: is the extended lifespan of calorie-restricted animals an evolutionary adaptation?</article-title><source>Bioessays</source><year>1989</year><volume>10</volume><fpage>125</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">2730632</pub-id></citation></ref><ref id="R5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barzilai</surname><given-names>N.</given-names></name><name><surname>Gupta</surname><given-names>G</given-names></name></person-group><article-title>Revisiting the role of fat mass in the life extension induced by caloric restriction</article-title><source>J. Gerontol. A Biol. Sci. Med. Sci</source><year>1999</year><volume>54</volume><fpage>B89</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">10191831</pub-id></citation></ref><ref id="R6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Yamaza</surname><given-names>H.</given-names></name><name><surname>Higami</surname><given-names>Y.</given-names></name><name><surname>Shimokawa</surname><given-names>I</given-names></name></person-group><article-title>Anti-aging effects of caloric restriction: Involvement of neuroendocrine adaptation by peripheral signaling</article-title><source>Microsc. Res. Tech</source><year>2002</year><volume>59</volume><fpage>317</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">12424795</pub-id></citation></ref><ref id="R7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katic</surname><given-names>M.</given-names></name><name><surname>Kahn</surname><given-names>C.R</given-names></name></person-group><article-title>The role of insulin and IGF-1 signaling in longevity</article-title><source>Cell. Mol. Life Sci</source><year>2005</year><volume>62</volume><fpage>320</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">15723168</pub-id></citation></ref><ref id="R8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimokawa</surname><given-names>I.</given-names></name><name><surname>Higami</surname><given-names>Y</given-names></name></person-group><article-title>A role for leptin in the antiaging action of dietary restriction: a hypothesis</article-title><source>Aging (Milano)</source><year>1999</year><volume>11</volume><fpage>380</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">10738853</pub-id></citation></ref><ref id="R9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bartke</surname><given-names>A</given-names></name></person-group><article-title>Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging</article-title><source>Endocrinology</source><year>2005</year><volume>146</volume><fpage>3718</fpage><lpage>3723</lpage><pub-id pub-id-type="pmid">15919742</pub-id></citation></ref><ref id="R10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kloting</surname><given-names>N.</given-names></name><name><surname>Bluher</surname><given-names>M</given-names></name></person-group><article-title>Extended longevity and insulin signaling in adipose tissue</article-title><source>Exp. Gerontol</source><year>2005</year><volume>40</volume><fpage>878</fpage><lpage>883</lpage><pub-id pub-id-type="pmid">16125891</pub-id></citation></ref><ref id="R11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>H.</given-names></name><name><surname>Masoro</surname><given-names>E.J.</given-names></name><name><surname>Nelson</surname><given-names>J.F.</given-names></name><name><surname>Strong</surname><given-names>R.</given-names></name><name><surname>McMahan</surname><given-names>C.A.</given-names></name><name><surname>Richardson</surname><given-names>A</given-names></name></person-group><article-title>Genetic mouse models of extended lifespan</article-title><source>Exp. Gerontol</source><year>2003</year><volume>38</volume><fpage>1353</fpage><lpage>1364</lpage><pub-id pub-id-type="pmid">14698816</pub-id></citation></ref><ref id="R12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Anzo</surname><given-names>M.</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name></person-group><article-title>Control of aging and longevity by IGF-I signaling</article-title><source>Exp. Gerontol</source><year>2005</year><volume>40</volume><fpage>867</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">16154307</pub-id></citation></ref><ref id="R13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bartke</surname><given-names>A.</given-names></name><name><surname>Wright</surname><given-names>J.C.</given-names></name><name><surname>Mattison</surname><given-names>J.A.</given-names></name><name><surname>Ingram</surname><given-names>D.K.</given-names></name><name><surname>Miller</surname><given-names>R.A.</given-names></name><name><surname>Roth</surname><given-names>G.S</given-names></name></person-group><article-title>Extending the lifespan of long-lived mice</article-title><source>Nature</source><year>2001</year><volume>414</volume><fpage>412</fpage><pub-id pub-id-type="pmid">11719795</pub-id></citation></ref><ref id="R14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimokawa</surname><given-names>I.</given-names></name><name><surname>Higami</surname><given-names>Y.</given-names></name><name><surname>Tsuchiya</surname><given-names>T.</given-names></name><name><surname>Otani</surname><given-names>H.</given-names></name><name><surname>Komatsu</surname><given-names>T.</given-names></name><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Yamaza</surname><given-names>H</given-names></name></person-group><article-title>Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction</article-title><source>FASEB J</source><year>2003</year><volume>17</volume><fpage>1108</fpage><lpage>1109</lpage><pub-id pub-id-type="pmid">12692087</pub-id></citation></ref><ref id="R15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimokawa</surname><given-names>I.</given-names></name><name><surname>Higami</surname><given-names>Y.</given-names></name><name><surname>Utsuyama</surname><given-names>M.</given-names></name><name><surname>Tuchiya</surname><given-names>T.</given-names></name><name><surname>Komatsu</surname><given-names>T.</given-names></name><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Yamaza</surname><given-names>H</given-names></name></person-group><article-title>Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model</article-title><source>Am. J. Pathol</source><year>2002</year><volume>160</volume><fpage>2259</fpage><lpage>2265</lpage><pub-id pub-id-type="pmid">12057928</pub-id></citation></ref><ref id="R16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hekimi</surname><given-names>S.</given-names></name><name><surname>Burgess</surname><given-names>J.</given-names></name><name><surname>Bussiere</surname><given-names>F.</given-names></name><name><surname>Meng</surname><given-names>Y.</given-names></name><name><surname>Benard</surname><given-names>C</given-names></name></person-group><article-title>Genetics of lifespan in <italic>C. elegans</italic>: molecular diversity physiological complexity mechanistic simplicity</article-title><source>Trends Genet</source><year>2001</year><volume>17</volume><fpage>712</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">11718925</pub-id></citation></ref><ref id="R17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sze</surname><given-names>J.Y.</given-names></name><name><surname>Victor</surname><given-names>M.</given-names></name><name><surname>Loer</surname><given-names>C.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Ruvkun</surname><given-names>G</given-names></name></person-group><article-title>Food and metabolic signalling defects in a <italic>Caenorhabditis elegans</italic> serotonin-synthesis mutant</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>560</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">10676966</pub-id></citation></ref><ref id="R18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>D.B.</given-names></name><name><surname>Johnson</surname><given-names>T.E</given-names></name></person-group><article-title>A mutation in the <italic>age-1</italic> gene in <italic>Caenorhabditis elegans</italic> lengthens life and reduces hermaphrodite fertility</article-title><source>Genetics</source><year>1988</year><volume>118</volume><fpage>75</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">8608934</pub-id></citation></ref><ref id="R19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>J.Z.</given-names></name><name><surname>Tissenbaum</surname><given-names>H.A.</given-names></name><name><surname>Ruvkun</surname><given-names>G</given-names></name></person-group><article-title>A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in <italic>Caenorhabditis elegans</italic></article-title><source>Nature</source><year>1996</year><volume>382</volume><fpage>536</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">8700226</pub-id></citation></ref><ref id="R20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clancy</surname><given-names>D.J.</given-names></name><name><surname>Gems</surname><given-names>D.</given-names></name><name><surname>Harshman</surname><given-names>L.G.</given-names></name><name><surname>Oldham</surname><given-names>S.</given-names></name><name><surname>Stocker</surname><given-names>H.</given-names></name><name><surname>Hafen</surname><given-names>E.</given-names></name><name><surname>Leevers</surname><given-names>S.J.</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name></person-group><article-title>Extension of life-span by loss of CHICO a <italic>Drosophila</italic> insulin receptor substrate protein</article-title><source>Science</source><year>2001</year><volume>292</volume><fpage>104</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">11292874</pub-id></citation></ref><ref id="R21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tatar</surname><given-names>M.</given-names></name><name><surname>Kopelman</surname><given-names>A.</given-names></name><name><surname>Epstein</surname><given-names>D.</given-names></name><name><surname>Tu</surname><given-names>M.P.</given-names></name><name><surname>Yin</surname><given-names>C.M.</given-names></name><name><surname>Garofalo</surname><given-names>R.S</given-names></name></person-group><article-title>A mutant <italic>Drosophila</italic> insulin receptor homolog that extends life-span and impairs neuroendocrine function</article-title><source>Science</source><year>2001</year><volume>292</volume><fpage>107</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">11292875</pub-id></citation></ref><ref id="R22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Inoue</surname><given-names>D.</given-names></name><name><surname>Mizuno</surname><given-names>A.</given-names></name><name><surname>Komatsu</surname><given-names>T.</given-names></name><name><surname>Fujita</surname><given-names>S.</given-names></name><name><surname>Kubota</surname><given-names>H.</given-names></name><name><surname>Luisa Tagliaro</surname><given-names>M.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Trindade</surname><given-names>L.S.</given-names></name><name><surname>Hayashida</surname><given-names>T.</given-names></name><name><surname>Hayashi</surname><given-names>H.</given-names></name><name><surname>Yamaza</surname><given-names>H.</given-names></name><name><surname>Higami</surname><given-names>Y.</given-names></name><name><surname>Shimokawa</surname><given-names>I</given-names></name></person-group><article-title>Identification and characterization of an insulin receptor substrate 4-interacting protein in rat brain: Implications for longevity</article-title><source>Neurobiol. Aging</source><year>2007</year><comment>doi: 10.1016/j.neurobiolaging. 2007.07.008</comment></citation></ref><ref id="R23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown-Borg</surname><given-names>H.M.</given-names></name><name><surname>Borg</surname><given-names>K.E.</given-names></name><name><surname>Meliska</surname><given-names>C.J.</given-names></name><name><surname>Bartke</surname><given-names>A</given-names></name></person-group><article-title>Dwarf mice and the ageing process</article-title><source>Nature</source><year>1996</year><volume>384</volume><fpage>33</fpage><pub-id pub-id-type="pmid">8900272</pub-id></citation></ref><ref id="R24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steger</surname><given-names>R.W.</given-names></name><name><surname>Bartke</surname><given-names>A.</given-names></name><name><surname>Cecim</surname><given-names>M</given-names></name></person-group><article-title>Premature ageing in transgenic mice expressing different growth hormone genes</article-title><source>J. Reprod. Fertil</source><year>1993</year><volume>46</volume><issue>Suppl</issue><fpage>61</fpage><lpage>75</lpage></citation></ref><ref id="R25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dominici</surname><given-names>F.P.</given-names></name><name><surname>Hauck</surname><given-names>S.</given-names></name><name><surname>Argentino</surname><given-names>D.P.</given-names></name><name><surname>Bartke</surname><given-names>A.</given-names></name><name><surname>Turyn</surname><given-names>D</given-names></name></person-group><article-title>Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice</article-title><source>J. Endocrinol</source><year>2002</year><volume>173</volume><fpage>81</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">11927387</pub-id></citation></ref><ref id="R26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flurkey</surname><given-names>K.</given-names></name><name><surname>Papaconstantinou</surname><given-names>J.</given-names></name><name><surname>Harrison</surname><given-names>D.E</given-names></name></person-group><article-title>The Snell dwarf mutation Pit1<sup>dw</sup> can increase life span in mice</article-title><source>Mech. Ageing. Dev</source><year>2002</year><volume>123</volume><fpage>121</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">11718806</pub-id></citation></ref><ref id="R27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Godfrey</surname><given-names>P.</given-names></name><name><surname>Rahal</surname><given-names>J.O.</given-names></name><name><surname>Beamer</surname><given-names>W.G.</given-names></name><name><surname>Copeland</surname><given-names>N.G.</given-names></name><name><surname>Jenkins</surname><given-names>N.A.</given-names></name><name><surname>Mayo</surname><given-names>K.E</given-names></name></person-group><article-title>GHRH receptor of <italic>little</italic> mice contains a missense mutation in the extracellular domain that disrupts receptor function</article-title><source>Nat. Genet</source><year>1993</year><volume>4</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">8395283</pub-id></citation></ref><ref id="R28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flurkey</surname><given-names>K.</given-names></name><name><surname>Papaconstantinou</surname><given-names>J.</given-names></name><name><surname>Miller</surname><given-names>R.A.</given-names></name><name><surname>Harrison</surname><given-names>D.E</given-names></name></person-group><article-title>Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2001</year><volume>98</volume><fpage>6736</fpage><lpage>6741</lpage><pub-id pub-id-type="pmid">11371619</pub-id></citation></ref><ref id="R29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fleenor</surname><given-names>D.</given-names></name><name><surname>Oden</surname><given-names>J.</given-names></name><name><surname>Kelly</surname><given-names>P.A.</given-names></name><name><surname>Mohan</surname><given-names>S.</given-names></name><name><surname>Alliouachene</surname><given-names>S.</given-names></name><name><surname>Pende</surname><given-names>M.</given-names></name><name><surname>Wentz</surname><given-names>S.</given-names></name><name><surname>Kerr</surname><given-names>J.</given-names></name><name><surname>Freemark</surname><given-names>M</given-names></name></person-group><article-title>Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency</article-title><source>Endocrinology</source><year>2005</year><volume>146</volume><fpage>103</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">15388648</pub-id></citation></ref><ref id="R30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaza</surname><given-names>H.</given-names></name><name><surname>Komatsu</surname><given-names>T.</given-names></name><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Toyama</surname><given-names>H.</given-names></name><name><surname>To</surname><given-names>K.</given-names></name><name><surname>Higami</surname><given-names>Y.</given-names></name><name><surname>Shimokawa</surname><given-names>I</given-names></name></person-group><article-title>A transgenic dwarf rat model as a tool for the study of calorie restriction and aging</article-title><source>Exp. Gerontol</source><year>2004</year><volume>39</volume><fpage>269</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">15036422</pub-id></citation></ref><ref id="R31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaza</surname><given-names>H.</given-names></name><name><surname>Komatsu</surname><given-names>T.</given-names></name><name><surname>To</surname><given-names>K.</given-names></name><name><surname>Toyama</surname><given-names>H.</given-names></name><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Higami</surname><given-names>Y.</given-names></name><name><surname>Shimokawa</surname><given-names>I</given-names></name></person-group><article-title>Involvement of insulin-like growth factor-1 in the effect of caloric restriction regulation of plasma adiponectin and leptin</article-title><source>J. Gerontol. A Biol. Sci. Med. Sci</source><year>2007</year><volume>62</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">17301034</pub-id></citation></ref><ref id="R32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>B.C.</given-names></name><name><surname>Maheshwari</surname><given-names>H.G.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Reed</surname><given-names>M.</given-names></name><name><surname>Lozykowski</surname><given-names>M.</given-names></name><name><surname>Okada</surname><given-names>S.</given-names></name><name><surname>Cataldo</surname><given-names>L.</given-names></name><name><surname>Coschigamo</surname><given-names>K.</given-names></name><name><surname>Wagner</surname><given-names>T.E.</given-names></name><name><surname>Baumann</surname><given-names>G.</given-names></name><name><surname>Kopchick</surname><given-names>J.J</given-names></name></person-group><article-title>A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1997</year><volume>94</volume><fpage>13215</fpage><lpage>13220</lpage><pub-id pub-id-type="pmid">9371826</pub-id></citation></ref><ref id="R33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coschigano</surname><given-names>K.T.</given-names></name><name><surname>Clemmons</surname><given-names>D.</given-names></name><name><surname>Bellush</surname><given-names>L.L.</given-names></name><name><surname>Kopchick</surname><given-names>J.J</given-names></name></person-group><article-title>Assessment of growth parameters and life span of GHR/BP gene-disrupted mice</article-title><source>Endocrinology</source><year>2000</year><volume>141</volume><fpage>2608</fpage><lpage>2613</lpage><pub-id pub-id-type="pmid">10875265</pub-id></citation></ref><ref id="R34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coschigano</surname><given-names>K.T.</given-names></name><name><surname>Holland</surname><given-names>A.N.</given-names></name><name><surname>Riders</surname><given-names>M.E.</given-names></name><name><surname>List</surname><given-names>E.O.</given-names></name><name><surname>Flyvbjerg</surname><given-names>A.</given-names></name><name><surname>Kopchick</surname><given-names>J.J</given-names></name></person-group><article-title>Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span</article-title><source>Endocrinology</source><year>2003</year><volume>144</volume><fpage>3799</fpage><lpage>3810</lpage><pub-id pub-id-type="pmid">12933651</pub-id></citation></ref><ref id="R35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonkowski</surname><given-names>M.S.</given-names></name><name><surname>Rocha</surname><given-names>J.S.</given-names></name><name><surname>Masternak</surname><given-names>M.M.</given-names></name><name><surname>Al Regaiey</surname><given-names>K.A.</given-names></name><name><surname>Bartke</surname><given-names>A</given-names></name></person-group><article-title>Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>7901</fpage><lpage>7905</lpage><pub-id pub-id-type="pmid">16682650</pub-id></citation></ref><ref id="R36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holzenberger</surname><given-names>M.</given-names></name><name><surname>Dupont</surname><given-names>J.</given-names></name><name><surname>Ducos</surname><given-names>B.</given-names></name><name><surname>Leneuve</surname><given-names>P.</given-names></name><name><surname>Geloen</surname><given-names>A.</given-names></name><name><surname>Even</surname><given-names>P.C.</given-names></name><name><surname>Cervera</surname><given-names>P.</given-names></name><name><surname>Le Bouc</surname><given-names>Y</given-names></name></person-group><article-title>IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice</article-title><source>Nature</source><year>2003</year><volume>421</volume><fpage>182</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">12483226</pub-id></citation></ref><ref id="R37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holzenberger</surname><given-names>M.</given-names></name><name><surname>Kappeler</surname><given-names>L.</given-names></name><name><surname>De Magalhaes Filho</surname><given-names>C</given-names></name></person-group><article-title>IGF-1 signaling and aging</article-title><source>Exp. Gerontol</source><year>2004</year><volume>39</volume><fpage>1761</fpage><lpage>1764</lpage><pub-id pub-id-type="pmid">15582293</pub-id></citation></ref><ref id="R38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bluher</surname><given-names>M.</given-names></name><name><surname>Kahn</surname><given-names>B.B.</given-names></name><name><surname>Kahn</surname><given-names>C.R</given-names></name></person-group><article-title>Extended longevity in mice lacking the insulin receptor in adipose tissue</article-title><source>Science</source><year>2003</year><volume>299</volume><fpage>572</fpage><lpage>574</lpage><pub-id pub-id-type="pmid">12543978</pub-id></citation></ref><ref id="R39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bluher</surname><given-names>M.</given-names></name><name><surname>Michael</surname><given-names>M.D.</given-names></name><name><surname>Peroni</surname><given-names>O.D.</given-names></name><name><surname>Ueki</surname><given-names>K.</given-names></name><name><surname>Carter</surname><given-names>N.</given-names></name><name><surname>Kahn</surname><given-names>B.B.</given-names></name><name><surname>Kahn</surname><given-names>C.R</given-names></name></person-group><article-title>Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance</article-title><source>Dev. Cell</source><year>2002</year><volume>3</volume><fpage>25</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">12110165</pub-id></citation></ref><ref id="R40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katic</surname><given-names>M.</given-names></name><name><surname>Kennedy</surname><given-names>A.R.</given-names></name><name><surname>Leykin</surname><given-names>I.</given-names></name><name><surname>Norris</surname><given-names>A.</given-names></name><name><surname>McGettrick</surname><given-names>A.</given-names></name><name><surname>Gesta</surname><given-names>S.</given-names></name><name><surname>Russell</surname><given-names>S.J.</given-names></name><name><surname>Bluher</surname><given-names>M.</given-names></name><name><surname>Maratos-Flier</surname><given-names>E.</given-names></name><name><surname>Kahn</surname><given-names>C.R</given-names></name></person-group><article-title>Mitochondrial gene expression and increased oxidative metabolism role in increased lifespan of fat-specific insulin receptor knock-out mice</article-title><source>Aging Cell</source><year>2007</year><volume>6</volume><fpage>827</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">18001293</pub-id></citation></ref><ref id="R41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Migliaccio</surname><given-names>E.</given-names></name><name><surname>Giorgio</surname><given-names>M.</given-names></name><name><surname>Mele</surname><given-names>S.</given-names></name><name><surname>Pelicci</surname><given-names>G.</given-names></name><name><surname>Reboldi</surname><given-names>P.</given-names></name><name><surname>Pandolfi</surname><given-names>P.P.</given-names></name><name><surname>Lanfrancone</surname><given-names>L.</given-names></name><name><surname>Pelicci</surname><given-names>P.G</given-names></name></person-group><article-title>The p66<sup>shc</sup> adaptor protein controls oxidative stress response and life span in mammals</article-title><source>Nature</source><year>1999</year><volume>402</volume><fpage>309</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">10580504</pub-id></citation></ref><ref id="R42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Migliaccio</surname><given-names>E.</given-names></name><name><surname>Mele</surname><given-names>S.</given-names></name><name><surname>Salcini</surname><given-names>A.E.</given-names></name><name><surname>Pelicci</surname><given-names>G.</given-names></name><name><surname>Lai</surname><given-names>K.M.</given-names></name><name><surname>Superti-Furga</surname><given-names>G.</given-names></name><name><surname>Pawson</surname><given-names>T.</given-names></name><name><surname>Di Fiore</surname><given-names>P.P.</given-names></name><name><surname>Lanfrancone</surname><given-names>L.</given-names></name><name><surname>Pelicci</surname><given-names>P.G</given-names></name></person-group><article-title>Opposite effects of the p52<sup>shc</sup>/p46<sup>shc</sup> and p66<sup>shc</sup> splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway</article-title><source>EMBO J</source><year>1997</year><volume>16</volume><fpage>706</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">9049300</pub-id></citation></ref><ref id="R43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nemoto</surname><given-names>S.</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name></person-group><article-title>Redox regulation of forkhead proteins through a p66<sup>shc</sup>-dependent signaling pathway</article-title><source>Science</source><year>2002</year><volume>295</volume><fpage>2450</fpage><lpage>2452</lpage><pub-id pub-id-type="pmid">11884717</pub-id></citation></ref><ref id="R44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>K.</given-names></name><name><surname>Hsin</surname><given-names>H.</given-names></name><name><surname>Libina</surname><given-names>N.</given-names></name><name><surname>Kenyon</surname><given-names>C</given-names></name></person-group><article-title>Regulation of the <italic>Caenorhabditis elegans</italic> longevity protein DAF-16 by insulin/IGF-1 and germline signaling</article-title><source>Nat. Genet</source><year>2001</year><volume>28</volume><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">11381260</pub-id></citation></ref><ref id="R45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selman</surname><given-names>C.</given-names></name><name><surname>Lingard</surname><given-names>S.</given-names></name><name><surname>Choudhury</surname><given-names>A.I.</given-names></name><name><surname>Batterham</surname><given-names>R.L.</given-names></name><name><surname>Claret</surname><given-names>M.</given-names></name><name><surname>Clements</surname><given-names>M.</given-names></name><name><surname>Ramadani</surname><given-names>F.</given-names></name><name><surname>Okkenhaug</surname><given-names>K.</given-names></name><name><surname>Schuster</surname><given-names>E.</given-names></name><name><surname>Blanc</surname><given-names>E.</given-names></name><name><surname>Piper</surname><given-names>M.D.</given-names></name><name><surname>Al-Qassab</surname><given-names>H.</given-names></name><name><surname>Speakman</surname><given-names>J.R.</given-names></name><name><surname>Carmignac</surname><given-names>D.</given-names></name><name><surname>Robinson</surname><given-names>I.C.</given-names></name><name><surname>Thornton</surname><given-names>J.M.</given-names></name><name><surname>Gems</surname><given-names>D..</given-names></name><name><surname>Partridge</surname><given-names>L.</given-names></name><name><surname>Withers</surname><given-names>D.J</given-names></name></person-group><article-title>Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice</article-title><source>FASEB J</source><year>2007</year><comment>doi:10.1096/fj.07-9261com</comment></citation></ref><ref id="R46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>F.</given-names></name><name><surname>Br&#x000fb;l&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Hee Um</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Masuda</surname><given-names>K.</given-names></name><name><surname>Roden</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>X.J.</given-names></name><name><surname>Krebs</surname><given-names>M.</given-names></name><name><surname>Polakiewicz</surname><given-names>R.D.</given-names></name><name><surname>Thomas</surname><given-names>G.</given-names></name><name><surname>Marette</surname><given-names>A</given-names></name></person-group><article-title>Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>14056</fpage><lpage>14061</lpage><pub-id pub-id-type="pmid">17709744</pub-id></citation></ref><ref id="R47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taguchi</surname><given-names>A.</given-names></name><name><surname>Wartschow</surname><given-names>L.M.</given-names></name><name><surname>White</surname><given-names>M.F</given-names></name></person-group><article-title>Brain IRS2 signaling coordinates life span and nutrient homeostasis</article-title><source>Science</source><year>2007</year><volume>317</volume><fpage>369</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">17641201</pub-id></citation></ref><ref id="R48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thirone</surname><given-names>A.C.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Klip</surname><given-names>A</given-names></name></person-group><article-title>Tissue-specific roles of IRS proteins in insulin signaling and glucose transport</article-title><source>Trends Endocrinol. Metab</source><year>2006</year><volume>17</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">16458527</pub-id></citation></ref><ref id="R49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Higami</surname><given-names>Y.</given-names></name><name><surname>Shimokawa</surname><given-names>I.</given-names></name><name><surname>Hosokawa</surname><given-names>M.</given-names></name><name><surname>Higuchi</surname><given-names>K</given-names></name></person-group><article-title>Identification of differentially expressed genes in senescence-accelerated mouse testes by suppression subtractive hybridization analysis</article-title><source>Mamm. Genome</source><year>2007</year><volume>18</volume><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">17334656</pub-id></citation></ref><ref id="R50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goren</surname><given-names>H.J.</given-names></name><name><surname>Kulkarni</surname><given-names>R.N.</given-names></name><name><surname>Kahn</surname><given-names>C.R</given-names></name></person-group><article-title>Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1</article-title><source>Endocrinology</source><year>2004</year><volume>145</volume><fpage>3307</fpage><lpage>3323</lpage><pub-id pub-id-type="pmid">15044376</pub-id></citation></ref><ref id="R51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Numan</surname><given-names>S.</given-names></name><name><surname>Russell</surname><given-names>D.S</given-names></name></person-group><article-title>Discrete expression of insulin receptor substrate-4 mRNA in adult rat brain</article-title><source>Brain Res. Mol. Brain Res</source><year>1999</year><volume>72</volume><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">10521603</pub-id></citation></ref><ref id="R52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krsmanovic</surname><given-names>L.Z.</given-names></name><name><surname>Stojilkovic</surname><given-names>S.S.</given-names></name><name><surname>Balla</surname><given-names>T.</given-names></name><name><surname>al-Damluji</surname><given-names>S.</given-names></name><name><surname>Weiner</surname><given-names>R.I.</given-names></name><name><surname>Catt</surname><given-names>K.J</given-names></name></person-group><article-title>Receptors and neurosecretory actions of endothelin in hypothalamic neurons</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1991</year><volume>88</volume><fpage>11124</fpage><lpage>11128</lpage><pub-id pub-id-type="pmid">1662384</pub-id></citation></ref><ref id="R53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neer</surname><given-names>E.J.</given-names></name><name><surname>Schmidt</surname><given-names>C.J.</given-names></name><name><surname>Nambudripad</surname><given-names>R.</given-names></name><name><surname>Smith</surname><given-names>T.F</given-names></name></person-group><article-title>The ancient regulatory-protein family of WD-repeat proteins</article-title><source>Nature</source><year>1994</year><volume>371</volume><fpage>297</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">8090199</pub-id></citation></ref><ref id="R54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>T.F.</given-names></name><name><surname>Gaitatzes</surname><given-names>C.</given-names></name><name><surname>Saxena</surname><given-names>K.</given-names></name><name><surname>Neer</surname><given-names>E.J</given-names></name></person-group><article-title>The WD repeat a common architecture for diverse functions</article-title><source>Trends Biochem. Sci</source><year>1999</year><volume>24</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">10322433</pub-id></citation></ref><ref id="R55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Burch</surname><given-names>P.</given-names></name><name><surname>Gonzalez</surname><given-names>O.</given-names></name><name><surname>Kashork</surname><given-names>C.D.</given-names></name><name><surname>Shaffer</surname><given-names>L.G.</given-names></name><name><surname>Bachinski</surname><given-names>L.L.</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name></person-group><article-title>Molecular cloning, expression analysis, and chromosome mapping of WDR6, a novel human WD-repeat gene</article-title><source>Biochem. Biophys. Res. Commun</source><year>2000</year><volume>274</volume><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">10903905</pub-id></citation></ref><ref id="R56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>T.</given-names></name><name><surname>Fujita</surname><given-names>S.</given-names></name><name><surname>Kubota</surname><given-names>H.</given-names></name><name><surname>Inoue</surname><given-names>D.</given-names></name><name><surname>Mizuno</surname><given-names>A.</given-names></name><name><surname>Komatsu</surname><given-names>T.</given-names></name><name><surname>Yamaza</surname><given-names>H.</given-names></name><name><surname>Higami</surname><given-names>Y.</given-names></name><name><surname>Shimokawa</surname><given-names>I</given-names></name></person-group><article-title>Identification of Fasting-induced Genes in the Rat Hypothalamus Relationship with Neuroprotection</article-title><source>Ann. NY Acad. Sci</source><year>2007</year><volume>1119</volume><fpage>216</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">18056970</pub-id></citation></ref><ref id="R57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diatchenko</surname><given-names>L.</given-names></name><name><surname>Lau</surname><given-names>Y.F.</given-names></name><name><surname>Campbell</surname><given-names>A.P.</given-names></name><name><surname>Chenchik</surname><given-names>A.</given-names></name><name><surname>Moqadam</surname><given-names>F.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Lukyanov</surname><given-names>S.</given-names></name><name><surname>Lukyanov</surname><given-names>K.</given-names></name><name><surname>Gurskaya</surname><given-names>N.</given-names></name><name><surname>Sverdlov</surname><given-names>E.D.</given-names></name><name><surname>Siebert</surname><given-names>P.D</given-names></name></person-group><article-title>Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1996</year><volume>93</volume><fpage>6025</fpage><lpage>6030</lpage><pub-id pub-id-type="pmid">8650213</pub-id></citation></ref><ref id="R58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>M.H.</given-names></name><name><surname>Geng</surname><given-names>A.B.</given-names></name><name><surname>Khan</surname><given-names>A.H.</given-names></name><name><surname>Qian</surname><given-names>W.J.</given-names></name><name><surname>Petyuk</surname><given-names>V.A.</given-names></name><name><surname>Boline</surname><given-names>J.</given-names></name><name><surname>Levy</surname><given-names>S.</given-names></name><name><surname>Toga</surname><given-names>A.W.</given-names></name><name><surname>Smith</surname><given-names>R.D.</given-names></name><name><surname>Leahy</surname><given-names>R.M.</given-names></name><name><surname>Smith</surname><given-names>D.J</given-names></name></person-group><article-title>A genome-scale map of expression for a mouse brain section obtained using voxelation</article-title><source>Physiol Genomics</source><year>2007</year><volume>30</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">17504947</pub-id></citation></ref><ref id="R59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liliental</surname><given-names>J.</given-names></name><name><surname>Chang</surname><given-names>D.D</given-names></name></person-group><article-title>Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit</article-title><source>J. Biol. Chem</source><year>1998</year><volume>273</volume><fpage>2379</fpage><lpage>2383</lpage><pub-id pub-id-type="pmid">9442085</pub-id></citation></ref><ref id="R60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Sale</surname><given-names>W.S</given-names></name></person-group><article-title>The Mr 140,000 intermediate chain of Chlamydomonas flagellar inner arm dynein is a WD-repeat protein implicated in dynein arm anchoring</article-title><source>Mol. Biol. Cell</source><year>1998</year><volume>9</volume><fpage>3335</fpage><lpage>3349</lpage><pub-id pub-id-type="pmid">9843573</pub-id></citation></ref><ref id="R61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hinsby</surname><given-names>A.M.</given-names></name><name><surname>Olsen</surname><given-names>J.V.</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><article-title>Tyrosine phosphoproteomics of fibroblast growth factor signaling: a role for insulin receptor substrate-4</article-title><source>J. Biol. Chem</source><year>2004</year><volume>279</volume><fpage>46438</fpage><lpage>46447</lpage><pub-id pub-id-type="pmid">15316024</pub-id></citation></ref><ref id="R62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hotta</surname><given-names>M.</given-names></name><name><surname>Kuriyama</surname><given-names>H.</given-names></name><name><surname>Arai</surname><given-names>K.</given-names></name><name><surname>Takano</surname><given-names>K.</given-names></name><name><surname>Shibasaki</surname><given-names>T</given-names></name></person-group><article-title>Fibroblast growth factor inhibits locomotor activity as well as feeding behavior of rats</article-title><source>Eur. J. Pharmacol</source><year>2001</year><volume>416</volume><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">11282118</pub-id></citation></ref><ref id="R63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fantin</surname><given-names>V.R.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Lienhard</surname><given-names>G.E.</given-names></name><name><surname>Keller</surname><given-names>S.R</given-names></name></person-group><article-title>Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis</article-title><source>Am. J. Physiol. Endocrinol. Metab</source><year>2000</year><volume>278</volume><fpage>E127</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">10644546</pub-id></citation></ref><ref id="R64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Association of LKB1 with a WD-repeat protein WDR6 is implicated in cell growth arrest and p27<sup>Kip1</sup> induction</article-title><source>Mol. Cell. Biochem</source><year>2007</year><volume>301</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">17216128</pub-id></citation></ref><ref id="R65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carling</surname><given-names>D</given-names></name></person-group><article-title>AMP-activated protein kinase: balancing the scales</article-title><source>Biochimie</source><year>2005</year><volume>87</volume><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">15733742</pub-id></citation></ref><ref id="R66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minokoshi</surname><given-names>Y.</given-names></name><name><surname>Alquier</surname><given-names>T.</given-names></name><name><surname>Furukawa</surname><given-names>N.</given-names></name><name><surname>Kim</surname><given-names>Y.B.</given-names></name><name><surname>Lee</surname><given-names>A.</given-names></name><name><surname>Xue</surname><given-names>B.</given-names></name><name><surname>Mu</surname><given-names>J.</given-names></name><name><surname>Foufelle</surname><given-names>F.</given-names></name><name><surname>Ferr&#x000e9;</surname><given-names>P.</given-names></name><name><surname>Birnbaum</surname><given-names>M.J.</given-names></name><name><surname>Stuck</surname><given-names>B.J.</given-names></name><name><surname>Kahn</surname><given-names>B.B</given-names></name></person-group><article-title>AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus</article-title><source>Nature</source><year>2004</year><volume>428</volume><fpage>569</fpage><lpage>574</lpage><pub-id pub-id-type="pmid">15058305</pub-id></citation></ref><ref id="R67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Shao</surname><given-names>S.H.</given-names></name><name><surname>Xu</surname><given-names>Z.X.</given-names></name><name><surname>Hennessy</surname><given-names>B.</given-names></name><name><surname>Ding</surname><given-names>Z.</given-names></name><name><surname>Larrea</surname><given-names>M.</given-names></name><name><surname>Kondo</surname><given-names>S.</given-names></name><name><surname>Dumont</surname><given-names>D.J.</given-names></name><name><surname>Gutterman</surname><given-names>J.U.</given-names></name><name><surname>Walker</surname><given-names>C.L.</given-names></name><name><surname>Slingerland</surname><given-names>J.M.</given-names></name><name><surname>Mills</surname><given-names>G.B</given-names></name></person-group><article-title>The energy sensing LKB1-AMPK pathway regulates p27<sup>kip1</sup> phosphorylation mediating the decision to enter autophagy or apoptosis</article-title><source>Nat. Cell Biol</source><year>2007</year><volume>9</volume><fpage>218</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">17237771</pub-id></citation></ref><ref id="R68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melendez</surname><given-names>A.</given-names></name><name><surname>Talloczy</surname><given-names>Z.</given-names></name><name><surname>Seaman</surname><given-names>M.</given-names></name><name><surname>Eskelinen</surname><given-names>E.L.</given-names></name><name><surname>Hall</surname><given-names>D.H.</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name></person-group><article-title>Autophagy genes are essential for dauer development and life-span extension <italic>C. elegans</italic></article-title><source>Science</source><year>2003</year><volume>301</volume><fpage>1387</fpage><lpage>1391</lpage><pub-id pub-id-type="pmid">12958363</pub-id></citation></ref><ref id="R69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>K.</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name></person-group><article-title>Autophagy is required for dietary restriction-mediated life span extension <italic>C. elegans</italic></article-title><source>Autophagy</source><year>2007</year><volume>3</volume><fpage>597</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">17912023</pub-id></citation></ref><ref id="R70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simonsen</surname><given-names>A.</given-names></name><name><surname>Cumming</surname><given-names>R.C.</given-names></name><name><surname>Brech</surname><given-names>A.</given-names></name><name><surname>Isakson</surname><given-names>P.</given-names></name><name><surname>Schubert</surname><given-names>D.R.</given-names></name><name><surname>Finley</surname><given-names>K.D</given-names></name></person-group><article-title>Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult <italic>Drosophila</italic></article-title><source>Autophagy</source><year>2007</year><volume>4</volume><comment>In press</comment></citation></ref><ref id="R71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>B.</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><article-title>Autophagy in cell death: an innocent convict?</article-title><source>J. Clin. Invest</source><year>2005</year><volume>115</volume><fpage>2679</fpage><lpage>2688</lpage><pub-id pub-id-type="pmid">16200202</pub-id></citation></ref><ref id="R72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nixon</surname><given-names>R.A</given-names></name></person-group><article-title>Autophagy in neurodegenerative disease: friend, foe or turncoat?</article-title><source>Trends Neurosci</source><year>2006</year><volume>29</volume><fpage>528</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">16859759</pub-id></citation></ref><ref id="R73"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergamini</surname><given-names>E.</given-names></name><name><surname>Cavallini</surname><given-names>G.</given-names></name><name><surname>Donati</surname><given-names>A.</given-names></name><name><surname>Gori</surname><given-names>Z</given-names></name></person-group><article-title>The role of macroautophagy in the ageing process, anti-ageing intervention and age-associated diseases</article-title><source>Int. J. Biochem. Cell. Biol</source><year>2004</year><volume>36</volume><fpage>2392</fpage><lpage>2404</lpage><pub-id pub-id-type="pmid">15325580</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="F1" position="float"><label>Fig. (1)</label><caption><p>Mammalian GH and insulin/IGF-I signaling pathways. Longevity related genes shown in Table <bold><xref ref-type="table" rid="T1">1</xref></bold> and discussed in text are shown in outlined characters on a gray background. Pituitary mutations cause GH/IGF-I-deficiency results in dwarf phenotypes, and increased insulin sensitivity in most cases. Mutations of receptors and intracellular signaling molecules are not necessary to increase insulin sensitivity for lifespan extension. These intracellular molecules could be points of intervention for therapies with the potential to delay the aging process.</p></caption><graphic xlink:href="CG-8-423_F1"/></fig><table-wrap id="T1" position="float"><label>Table 1.</label><caption><p>Rodent Longevity Models of Modified Insulin/GH/IGF-I Signaling</p></caption><table frame="border" rules="all" width="100%"><thead><tr><th rowspan="1" colspan="1">Rodent Models</th><th rowspan="1" colspan="1">Responsive Gene</th><th rowspan="1" colspan="1">Effect<xref ref-type="table-fn" rid="T1FN1">a</xref></th><th rowspan="1" colspan="1">Lifespan<xref ref-type="table-fn" rid="T1FN2">b</xref></th><th rowspan="1" colspan="1">Body Weight<xref ref-type="table-fn" rid="T1FN3">c</xref></th><th rowspan="1" colspan="1">IGF-I</th><th rowspan="1" colspan="1">Insulin Sensitivity</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Ames mice</td><td align="center" rowspan="1" colspan="1"><italic>Prop-1</italic></td><td align="center" rowspan="1" colspan="1">Pituitary</td><td align="center" rowspan="1" colspan="1">&#x02642;49%,&#x02640;68%</td><td align="center" rowspan="1" colspan="1">33%</td><td align="center" rowspan="1" colspan="1">Decreased</td><td align="center" rowspan="1" colspan="1">Increased</td></tr><tr><td align="center" rowspan="1" colspan="1">Snell mice</td><td align="center" rowspan="1" colspan="1"><italic>Pit-1</italic></td><td align="center" rowspan="1" colspan="1">Pituitary</td><td align="center" rowspan="1" colspan="1">&#x02642;26%,&#x02640;42%</td><td align="center" rowspan="1" colspan="1">33%</td><td align="center" rowspan="1" colspan="1">Decreased</td><td align="center" rowspan="1" colspan="1">Increased</td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>Ghrhr<sup>lit/lit</sup></italic>mice</td><td align="center" rowspan="1" colspan="1"><italic>Ghrhr</italic></td><td align="center" rowspan="1" colspan="1">Pituitary</td><td align="center" rowspan="1" colspan="1">&#x02642;23%,&#x02640;25%</td><td align="center" rowspan="1" colspan="1">67%</td><td align="center" rowspan="1" colspan="1">Decreased</td><td align="center" rowspan="1" colspan="1">Unchanged</td></tr><tr><td align="center" rowspan="1" colspan="1">GH-antisense TG	rats</td><td align="center" rowspan="1" colspan="1">GH-antisense</td><td align="center" rowspan="1" colspan="1">Pituitary</td><td align="center" rowspan="1" colspan="1">&#x02642;10%</td><td align="center" rowspan="1" colspan="1">66%</td><td align="center" rowspan="1" colspan="1">Decreased</td><td align="center" rowspan="1" colspan="1">Increased</td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>GHR/BP<sup>-/-</sup></italic> mice</td><td align="center" rowspan="1" colspan="1"><italic>GHR/BP</italic></td><td align="center" rowspan="1" colspan="1">Receptor</td><td align="center" rowspan="1" colspan="1">&#x02642;55%,&#x02640;38%</td><td align="center" rowspan="1" colspan="1">40-41%</td><td align="center" rowspan="1" colspan="1">Decreased</td><td align="center" rowspan="1" colspan="1">Increased</td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>Igf1r<sup>+/-</sup></italic>mice</td><td align="center" rowspan="1" colspan="1"><italic>Igf1r</italic></td><td align="center" rowspan="1" colspan="1">Receptor</td><td align="center" rowspan="1" colspan="1">&#x02640;33%</td><td align="center" rowspan="1" colspan="1">92-94%</td><td align="center" rowspan="1" colspan="1">Increased</td><td align="center" rowspan="1" colspan="1">Increased</td></tr><tr><td align="center" rowspan="1" colspan="1">FIRKO mice</td><td align="center" rowspan="1" colspan="1"><italic>IR </italic>(fat-specific)</td><td align="center" rowspan="1" colspan="1">Receptor</td><td align="center" rowspan="1" colspan="1">&#x02642;+&#x02640;18%</td><td align="center" rowspan="1" colspan="1">75-85%</td><td align="center" rowspan="1" colspan="1">Unchanged</td><td align="center" rowspan="1" colspan="1">Increased</td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>p66<sup>shc-/-</sup></italic>mice</td><td align="center" rowspan="1" colspan="1"><italic>p66<sup>shc</sup></italic></td><td align="center" rowspan="1" colspan="1">Intracellular</td><td align="center" rowspan="1" colspan="1">&#x02642;+&#x02640;30%</td><td align="center" rowspan="1" colspan="1">100%</td><td align="center" rowspan="1" colspan="1">Unknown</td><td align="center" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>Irs1<sup>-/-</sup></italic>mice</td><td align="center" rowspan="1" colspan="1"><italic>Irs1</italic></td><td align="center" rowspan="1" colspan="1">Intracellular</td><td align="center" rowspan="1" colspan="1">&#x02640;32%</td><td align="center" rowspan="1" colspan="1">60-65%</td><td align="center" rowspan="1" colspan="1">Unchanged</td><td align="center" rowspan="1" colspan="1">Decreased</td></tr><tr><td align="center" rowspan="1" colspan="1"><italic>bIrs2<sup>+/-</sup></italic>mice</td><td align="center" rowspan="1" colspan="1"><italic>Irs2 </italic>(brain-specific)</td><td align="center" rowspan="1" colspan="1">Intracellular</td><td align="center" rowspan="1" colspan="1">&#x02642;18%</td><td align="center" rowspan="1" colspan="1">95-100%</td><td align="center" rowspan="1" colspan="1">Unknown</td><td align="center" rowspan="1" colspan="1">Decreased</td></tr></tbody></table><table-wrap-foot><fn id="T1FN1"><label>a</label><p>Site of primary effect of the mutation.</p></fn><fn id="T1FN2"><label>b</label><p>% increase of lifespan in mutants compared to control animals.</p></fn><fn id="T1FN3"><label>c</label><p>% of body weight compared to control animals (6 to 10 months old).</p></fn></table-wrap-foot></table-wrap></floats-wrap></article>